{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:16:34Z","timestamp":1790255794259,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/ftd.0b013e3181898b6f","type":"journal-article","created":{"date-parts":[[2008,11,21]],"date-time":"2008-11-21T03:16:16Z","timestamp":1227237376000},"page":"709-716","source":"Crossref","is-referenced-by-count":116,"title":["Caffeine Citrate Treatment for Extremely Premature Infants With Apnea: Population Pharmacokinetics, Absolute Bioavailability, and Implications for Therapeutic Drug Monitoring"],"prefix":"10.1097","volume":"30","author":[{"given":"Bruce G","family":"Charles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki J","family":"Flenady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Shearman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJM199904013401311","article-title":"Bronchopulmonary dysplasia: no simple solution.","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"issue":"Suppl A","key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1016\/S1526-0542(04)90067-X","article-title":"Apnoea of prematurity.","volume":"5","author":"Martin","year":"2004","journal-title":"Pediatr Respir Rev"},{"key":"R4-11-20210129","first-page":"F499","article-title":"Effect of caffeine and theophylline on control of breathing in infantile apnea.","volume":"89","author":"Aranda","year":"1983","journal-title":"J Pediatr"},{"key":"R5-11-20210129","first-page":"429","article-title":"The effects of caffeine and theophylline on diaphragm contractility.","volume":"130","author":"Supinski","year":"1984","journal-title":"Am Rev Resp Dis"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0095-5108(18)31165-5","article-title":"Methylxanthines in apnea of prematurity.","volume":"6","author":"Aranda","year":"1979","journal-title":"Clin Perinatol"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"F499","DOI":"10.1136\/adc.2002.023432","article-title":"High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.","volume":"89","author":"Steer","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(79)80047-5","article-title":"Pharmacokinetic profile of caffeine in the premature newborn infant with apnea.","volume":"94","author":"Aranda","year":"1979","journal-title":"J Pediatr"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1440-1754.2003.00207.x","article-title":"Periextubation caffeine in preterm neonates: a randomized dose response trial.","volume":"39","author":"Steer","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","article-title":"Caffeine citrate for the treatment of apnea of prematurity: a double blind, placebo-controlled study.","volume":"20","author":"Erenberg","year":"2000","journal-title":"Pharmacotherapy"},{"key":"R12-11-20210129","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1542\/peds.43.4.510","article-title":"Apnea in premature infants: monitoring, incidence, heart rate change, and an effect of environmental temperature.","volume":"43","author":"Daily","year":"1969","journal-title":"Pediatrics"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1542\/peds.50.1.40","article-title":"Morbidity and mortality of infants weighing less than 1000 grams in an intensive care nursery.","volume":"50","author":"Alden","year":"1972","journal-title":"Pediatrics"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1651-2227.1995.tb13649.x","article-title":"Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.","volume":"84","author":"Larsen","year":"1995","journal-title":"Acta Paediatr"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-3732(97)00038-6","article-title":"Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants.","volume":"50","author":"Laubscher","year":"1998","journal-title":"Early Hum Dev"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-999549","article-title":"Comparative evaluation of caffeine and theophylline for weaning premature infants from the ventilator.","volume":"6","author":"Sims","year":"1989","journal-title":"Am J Perinatol"},{"key":"R17-11-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/adc.67.4_Spec_No.425","article-title":"Caffeine or theophylline for neonatal apnoea?","volume":"67","author":"Scanlon","year":"1992","journal-title":"Arch Dis Child"},{"key":"R18-11-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology-drug disposition, action, and therapy in infants and children.","volume":"349","author":"Kearns","year":"2006","journal-title":"N Engl J Med"},{"key":"R19-11-20210129","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1345\/aph.1D374","article-title":"Population pharmacokinetics. I: background, concepts and models.","volume":"38","author":"Ette","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R20-11-20210129","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1023\/A:1016215116835","article-title":"Population pharmacokinetic modelling: the importance of informative graphics.","volume":"12","author":"Ette","year":"1995","journal-title":"Pharm Res"},{"key":"R21-11-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","article-title":"A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.","volume":"59","author":"Parke","year":"1999","journal-title":"Comp Meth Progr Biomed"},{"key":"R22-11-20210129","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics.","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"R23-11-20210129","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1651-2227.1979.tb18446.x","article-title":"Gastric emptying in preterm infants.","volume":"68","author":"Cavell","year":"1979","journal-title":"Acta Paediatr Scand"},{"key":"R24-11-20210129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003088-198814040-00001","article-title":"Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (part I).","volume":"14","author":"Besunder","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"R25-11-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.1982.132","article-title":"Caffeine disposition after oral doses.","volume":"32","author":"Bonati","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"R26-11-20210129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0002-9610(66)90171-1","article-title":"Gastric acid secretion and parietal cell mass in the stomach of the newborn infant.","volume":"11","author":"Polacek","year":"1966","journal-title":"Am J Surg"},{"key":"R27-11-20210129","first-page":"252","article-title":"Gastric acidity in the first ten days of life of the prematurely born baby.","volume":"100","author":"Ames","year":"1960","journal-title":"Am J Dis Child"},{"key":"R29-11-20210129","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.284.5420.1677","article-title":"The fourth dimension of life: fractal geometry and allometric scaling of organisms.","volume":"284","author":"West","year":"1999","journal-title":"Science"},{"key":"R30-11-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002280050734","article-title":"The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor.","volume":"56","author":"Akinyinka","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R31-11-20210129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/00912700122010500","article-title":"Caffeine metabolism in premature infants.","volume":"41","author":"Al-Alaiyan","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"R32-11-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s002280050276","article-title":"Population pharmacokinetics of caffeine in premature neonates.","volume":"52","author":"Falcao","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"R33-11-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2125.2002.01589.x","article-title":"Caffeine in apnoeic Asian neonates: a sparse data analysis.","volume":"54","author":"Lee","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"R34-11-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/clpt.1988.129","article-title":"Maturation of caffeine metabolic pathways in infancy.","volume":"44","author":"Carrier","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"R35-11-20210129","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00007691-199606000-00005","article-title":"Population pharmacokinetics of caffeine in neonates and young infants.","volume":"18","author":"Thomson","year":"1996","journal-title":"Ther Drug Monit"},{"key":"R36-11-20210129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0009-9236(97)90097-7","article-title":"Population pharmacokinetics of intravenous caffeine in neonates with apnea of prematurity.","volume":"61","author":"Lee","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"R37-11-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00606424","article-title":"Pharmacokinetic aspects of caffeine in premature infants with apnoea.","volume":"2","author":"Gorodischer","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"R38-11-20210129","first-page":"1124","article-title":"Standards of laboratory practice: theophylline and caffeine monitoring.","volume":"44","author":"Pesce","year":"1998","journal-title":"Clin Chem"},{"key":"R39-11-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00007691-198703000-00017","article-title":"Caffeine enzyme immunoassay in neonatal and pediatric drug monitoring.","volume":"9","author":"Aranda","year":"1987","journal-title":"Ther Drug Monit"},{"key":"R40-11-20210129","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00007691-200106000-00011","article-title":"Use of saliva in therapeutic drug monitoring of caffeine in preterm infants.","volume":"23","author":"De Wildt","year":"2001","journal-title":"Ther Drug Monit"},{"key":"R41-11-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0378-4347(95)00383-5","article-title":"Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma.","volume":"677","author":"Schreiber-Deturmeny","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R42-11-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/0310057X9902700316","article-title":"Caffeine overdose in a premature infant: clinical course and pharmacokinetics.","volume":"27","author":"Anderson","year":"1999","journal-title":"Anaesth Intensive Care"},{"key":"R43-11-20210129","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1542\/peds.2006-2986","article-title":"Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise?","volume":"119","author":"Natarajan","year":"2007","journal-title":"Pediatrics"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e3181898b6f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:15:04Z","timestamp":1786036504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200812000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181898b6f","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}